Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic disorders with episodic manifestations: focus on epilepsy and migraine.

Literature DB >> 16426991

Chronic disorders with episodic manifestations: focus on epilepsy and migraine.

Sheryl R Haut¹, Marcelo E Bigal², Richard B Lipton³.

Abstract

Epilepsy and migraine are chronic neurological disorders with episodic manifestations that are commonly treated in neurological practice and frequently occur together. In this review we examine similarities and contrasts between these disorders, with focus on epidemiology and classification, temporal coincidence, triggers, and mechanistically based therapeutic overlap. This investigation draws attention to unique aspects of both epilepsy and migraine, while identifying areas of crossover in which each specialty could benefit from the experience of the other.

Entities: Disease

Mesh：

Year: 2006 PMID： 16426991 PMCID： PMC1457022 DOI： 10.1016/S1474-4422(06)70348-9

Source DB: PubMed Journal: Lancet Neurol ISSN： 1474-4422 Impact factor: 44.182

94 in total

1. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura.

Authors: T J Steiner; L J Findley; A W Yuen
Journal: Cephalalgia Date: 1997-04 Impact factor: 6.292

2. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches.

Authors: A Mauskop
Journal: Cephalalgia Date: 2005-02 Impact factor: 6.292

3. Lamotrigine in the prophylactic treatment of migraine aura--a pilot study.

Authors: C Lampl; A Buzath; D Klinger; K Neumann
Journal: Cephalalgia Date: 1999-01 Impact factor: 6.292

4. Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors: R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal: Headache Date: 2001 Jul-Aug Impact factor: 5.887

5. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial.

Authors: A Marson; A Jacoby; A Johnson; L Kim; C Gamble; D Chadwick
Journal: Lancet Date: 2005 Jun 11-17 Impact factor: 79.321

6. Sleep deprivation and epilepsy.

Authors: Beth A Malow
Journal: Epilepsy Curr Date: 2004 Sep-Oct Impact factor: 7.500

7. Actions at GABA(A) receptors in the hippocampus may mediate some antiseizure effects of progestins.

Authors: Madeline E Rhodes; Cheryl A Frye
Journal: Epilepsy Behav Date: 2005-05 Impact factor: 2.937

8. Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation.

Authors: W van der Kamp; A Maassen VanDenBrink; M D Ferrari; J G van Dijk
Journal: J Neurol Sci Date: 1996-07 Impact factor: 3.181

9. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy.

Authors: Andrew G Herzog; Cynthia L Harden; Joyce Liporace; Page Pennell; Donald L Schomer; Michael Sperling; Kristen Fowler; Blagovast Nikolov; Sevie Shuman; Melanee Newman
Journal: Ann Neurol Date: 2004-09 Impact factor: 10.422

10. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.

Authors: Frederick G Freitag; S D Collins; H A Carlson; J Goldstein; J Saper; S Silberstein; N Mathew; P K Winner; R Deaton; K Sommerville
Journal: Neurology Date: 2002-06-11 Impact factor: 9.910

90 in total

Review 1. Management of headache in the elderly.

Authors: Matthew S Robbins; Richard B Lipton
Journal: Drugs Aging Date: 2010-05 Impact factor: 3.923

Review 2. Transcranial magnetic simulation in the treatment of migraine.

Authors: Richard B Lipton; Starr H Pearlman
Journal: Neurotherapeutics Date: 2010-04 Impact factor: 7.620

3. Migraine prevalence, socioeconomic status, and social causation.

Authors: Walter F Stewart; Jason Roy; Richard B Lipton
Journal: Neurology Date: 2013-08-29 Impact factor: 9.910

Review 4. Tumour necrosis factor gene polymorphisms and migraine: a systematic review and meta-analysis.

Authors: Markus Schürks; Pamela M Rist; Robert Yl Zee; Daniel I Chasman; Tobias Kurth
Journal: Cephalalgia Date: 2011-10 Impact factor: 6.292

Review 5. Central mechanism of action of antimigraine prophylactic drugs.

Authors: Gerardo Casucci; Veronica Villani; Fabio Frediani
Journal: Neurol Sci Date: 2008-05 Impact factor: 3.307

Review 6. Migraine and mortality: a systematic review and meta-analysis.

Authors: Markus Schürks; Pamela M Rist; Robert E Shapiro; Tobias Kurth
Journal: Cephalalgia Date: 2011-07-29 Impact factor: 6.292

7. Association of endothelial nitric oxide synthase gene polymorphisms (894G/T, -786T/C, G10T) and clinical findings in patients with migraine.

Authors: Recep Eröz; Anzel Bahadir; Suber Dikici; Sener Tasdemir
Journal: Neuromolecular Med Date: 2014-05-22 Impact factor: 3.843